Will Pfizer (NYSE: PFE) Suffer The Same Fate As Merck (NYSE: MRK)?

Pfizer (NYSE: PFE) prepares to report on Tuesday. Consensus says that earnings of $0.51 are expected on revenue of $16.69 billion. Merck (NYSE: MRK), the other drug giant, earned $0.85 last Friday, but missed revenue estimates. The company made $11.12 billion in sales when analysts were expecting $11.24 billion. The company also lowered its guidance.

Merck closed Friday's trading day at $36.31, while Pfizer closed at $17.42.

Will Pfizer Suffer The Same Fate As Merck? (NYSE: PFE) (NYSE: MRK)

Pfizer prepares to report on Tuesday. Consensus says that earnings of $0.51 are expected on revenue of $16.69 billion. Merck, the other drug giant, earned $0.85 last Friday, but missed revenue estimates. The company made $11.12 billion in sales when analysts were expecting $11.24 billion. The company also lowered its guidance.

Down Jones Industrial Average

At early morning most stocks are declining on the Dow Jones. Bank of America is down over 6%. BAC reported a profit of nearly 3 billion and stated that non performing loans declined as charge-offs of loans gone sour fell. Traders sent BAC lower on skepticism of their ability to execute in the future. General Electric reported a profit of over 3 billion. GE's top line growth fell from the previous year which is in focus today by the markets. The markets have sent GE shares spinning 3%. Alcoa is down another 1.3% today in trading news. There is a quiet whisper on Wall Street that Alcoa will be replaced in the Dow Jones. Pfizer is currently level on the day with a quiet whisper on their ability to develop new drugs. This has sent Merck tumbling .36% as a new push by Pfizer means declining sales for Merck.